Thanks to everyone who has contributed to achieving this milestone. It has been a frenetic few days since the last update with several media interviews including one with Reuters news agency and TV interviews on WSBT Atlanta and the Canadian Broadcasting Corporation news: http://www.reuters.com/article/2014/08/02/health-ebola-fda-idUSL2N0Q802R20140802 http://www.cbc.ca/player/News/ID/2482604307/ Our efforts has elicited a second media response from the FDA: http://www.wsbtv.com/news/news/local/fda-issues-statement-regarding-call-expedite-proce/ngtLD/ This FDA response signifies that thanks to you the FDA is listening, but we are still waiting for action. At this stage we will add another experimental drug for fast track consideration by the FDA namely Zmapp produced by Mapp Biopharmaceutical Inc. to this petition. This experimental drug was used on the Ebola infected American aid workers Dr. Keith Brantley and Nancy Writebol with highly encouraging initial results. At this stage it is prudent that it undergo the trials to determine whether the rest of humanity can benefit from it. The petition will be updated accordingly. We also invite all other drug manufactures currently and previously involved in Ebola research to join the race - not for a county track meet but for the Olympic gold medal of making this the last Ebola epidemic without a cure or vaccine. Again, let’s save lives together.